SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001855763-24-000009
Filing Date
2024-05-10
Accepted
2024-05-10 17:16:29
Documents
1
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7852
  Complete submission text file 0001855763-24-000009.txt   9444
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612
Business Address
TURKEL CATHERINE C. (Reporting) CIK: 0001705278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 24936018